Testing effectiveness (Phase 2)Looking for participantsNCT05788679
What this trial is testing
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% BlastsMixed Myelodysplastic/Myeloproliferative Disease
Karolinska University Hospital 200